Markus Mayer

Markus Mayer

Company: Alentis

Job title: Vice President of R&D


Discovering the Effect of Anti-Claudin-1 Antibodies in Preclinical Models of Liver Fibrosis & Cancer 2:00 pm

• Deep diving into translational models: ex vivo human (liver spheroids, liver slices), mice with humanized livers, predictive liver signature • Investigating Claudin-1 as a therapeutic target in advanced liver diseaseRead more

day: Day 1 Stream 2 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.